Cesar Sommer

Cesar Sommer is an experienced biomedical scientist currently serving as Executive Director at Allogene Therapeutics, where prior roles included Senior Director, Director, Associate Director, and Principal Scientist, with a focus on cancer immunotherapy involving CAR T cells and bispecific antibodies. At Pfizer, Cesar Sommer held the position of Principal Scientist and Senior Scientist, concentrating on the preclinical development of CAR-T cell therapies and optimizing gene editing techniques. Earlier, as a Postdoctoral Fellow at Boston University, significant contributions included developing a reprogramming platform for clinical-grade iPSC lines and exploring cancer mechanisms using genetically-engineered cell lines. Cesar Sommer holds a Ph.D. in Molecular Genetics from UFSCar and a B.S. in Genetics from Universidad Nacional de Misiones.